Načítá se...
MicroRNA Mediated Cardioprotection – Is There a Path to Clinical Translation?
In the past 20 years, there have been several approaches to achieve cardioprotection or cardiac regeneration using a vast variety of cell therapies and remote ischemic pre-conditioning (RIPC). To date, substantial proof that either cell therapy or RIPC has the potential for clinically relevant cardi...
Uloženo v:
| Vydáno v: | Front Bioeng Biotechnol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7099408/ https://ncbi.nlm.nih.gov/pubmed/32266222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00149 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|